CDK1 and colorectal carcinoma: MiR-145 has been reported to suppress the proliferation, cell cycle, apoptosis, angiogenesis, and migration of CRC cells through directly targeting several oncogenes such as c-Myc [22], CDK1 [23], and Friend leukemia virus integration 1 gene (FLI1) [24].